These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 3568693)

  • 21. Multi-institutional randomized clinical trials as a research method in cancer.
    Ortiz HG
    Int J Radiat Oncol Biol Phys; 1985 May; 11(5):1053-6. PubMed ID: 3988555
    [No Abstract]   [Full Text] [Related]  

  • 22. Approaches to sample size estimation in the design of clinical trials--a review.
    Donner A
    Stat Med; 1984; 3(3):199-214. PubMed ID: 6385187
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Power and sample size simulations for Randomized Play-the-Winner rules.
    Guimaraes P; Palesch Y
    Contemp Clin Trials; 2007 Jul; 28(4):487-99. PubMed ID: 17321219
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sample size requirements and the cost of a randomized clinical trial with repeated measurements.
    Bloch DA
    Stat Med; 1986; 5(6):663-7. PubMed ID: 3823673
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Early stopping in the two-sample problem for bounded random variables.
    DeMets DL; Halperin M
    Control Clin Trials; 1982 Mar; 3(1):1-11. PubMed ID: 7067469
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A comparison of adaptive allocation rules for group-sequential binary response clinical trials.
    Morgan CC; Stephen Coad D
    Stat Med; 2007 Apr; 26(9):1937-54. PubMed ID: 16981177
    [TBL] [Abstract][Full Text] [Related]  

  • 27. "Proving the null hypothesis" in clinical trials.
    Blackwelder WC
    Control Clin Trials; 1982 Dec; 3(4):345-53. PubMed ID: 7160191
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sensitivity and specificity of clinical trials. Randomized v historical controls.
    Sacks HS; Chalmers TC; Smith H
    Arch Intern Med; 1983 Apr; 143(4):753-5. PubMed ID: 6838297
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Validity and treatment dilution in Zelen's single consent design.
    McHugh R
    Stat Med; 1984; 3(3):215-8. PubMed ID: 6484375
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tables of power for the F-test for comparing two exponential survival distributions.
    Lesser ML; Cento SJ
    J Chronic Dis; 1981; 34(11):533-44. PubMed ID: 7287858
    [No Abstract]   [Full Text] [Related]  

  • 31. Sample size determination based on Fisher's Exact Test for use in 2 x 2 comparative trials with low event rates.
    Thomas RG; Conlon M
    Control Clin Trials; 1992 Apr; 13(2):134-47. PubMed ID: 1316828
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Planning the size of survival time clinical trials with allowance for stratification.
    Moussa MA
    Stat Med; 1988 May; 7(5):559-69. PubMed ID: 3387715
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of multiple comparisons in randomized clinical trials.
    Smith DG; Clemens J; Crede W; Harvey M; Gracely EJ
    Am J Med; 1987 Sep; 83(3):545-50. PubMed ID: 3661589
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sample size in clinical trials with dichotomous endpoints: use of covariables.
    Choi SC
    J Biopharm Stat; 1998 Jul; 8(3):367-75. PubMed ID: 9741853
    [TBL] [Abstract][Full Text] [Related]  

  • 35. When was a "negative" clinical trial big enough? How many patients you needed depends on what you found.
    Detsky AS; Sackett DL
    Arch Intern Med; 1985 Apr; 145(4):709-12. PubMed ID: 3985731
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sample size determination for quadratic inference functions in longitudinal design with dichotomous outcomes.
    Hu Y; Song PX
    Stat Med; 2012 Apr; 31(8):787-800. PubMed ID: 22362611
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Statistical aspects of intraperitoneal chemotherapy studies.
    Stablein D
    Semin Oncol; 1985 Sep; 12(3 Suppl 4):121-3. PubMed ID: 4048972
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Patients and physicians as obstacles to a randomized trial.
    Lacher MJ
    Semin Oncol; 1981 Dec; 8(4):424-9. PubMed ID: 7323814
    [No Abstract]   [Full Text] [Related]  

  • 39. Designing and analyzing clinical trials which allow institutions to randomize patients to a subset of the treatments under study.
    Schoenfeld DA; Gelber RD
    Biometrics; 1979 Dec; 35(4):825-9. PubMed ID: 526527
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bias and loss: the two sides of a biased coin.
    Atkinson AC
    Stat Med; 2012 Dec; 31(28):3494-503. PubMed ID: 22736426
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.